Biogen (BIIB) option implied volatility into Clinical Trials on Alzheimer's Congress

Biogen (NASDAQ: BIIB) November weekly option implied volatility is at 22, December weekly is at 55, December is at 56; compared to its 52-week range 29 to 97 into data will be peer reviewed and presented Nov. 29 at the Clinical Trials on Alzheimer's Congress.

You May Also Be Interested In

• Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
• Lionsgate Studios (LION) June 16, 17 and 18 calls active
• Biogen (BIIB) Reiterated at Overweight by Cantor Fitzgerald: Advancing with BIIB080